Search This Blog

Friday, January 09, 2009

POSSIBLE NON-STEROIDAL TREATMENT FOR UVEITIS

Journal of Clinical Ophthalmology - Dove Medical Press:

"Currently available uveitis therapies are burdened with toxicities and/or lack definitive evidence of efficacy. Voclosporin, a rationally designed novel calcineurin inhibitor, exhibits a favorable safety profile and a wide therapeutic window. If LUMINATE is successful, voclosporin will become the first Food and Drug Administration-approved corticosteroid-sparing agent for this condition."

No comments:

Post a Comment

Leave a Comment or Question: